Active ingredientMoxonidineCat. No. P-M177-001CAS 75438-57-2Family · Pharmaceutical analytical standards
Moxonidine
A second-generation centrally acting antihypertensive, first marketed in Germany in 1991: it stimulates type I1 imidazoline receptors and so lowers the activity of the sympathetic nervous system; it is used for mild to moderate essential hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It binds the I1 receptor about 33 times more strongly than alpha-2 receptors, whereas for clonidine, the earlier-generation centrally acting antihypertensive, the ratio is about 4 times.
Go to the active ingredient →Active ingredientMoxonidineCat. No. P-M177-001CAS 75438-57-2
Pharmacopoeial impurityMoxonidine EP Impurity ACat. No. P-M177-002CAS 352457-35-3
Pharmacopoeial impurityMoxonidine EP Impurity BCat. No. P-M177-003CAS 75439-01-9
Pharmacopoeial impurityMoxonidine EP Impurity CCat. No. P-M177-004CAS 352457-34-2
Pharmacopoeial impurityMoxonidine EP Impurity DCat. No. P-M177-005CAS 352457-33-1
Isotopically labelledMoxonidine-13C-d3Cat. No. P-M177-006
Isotopically labelledMoxonidine-d3Cat. No. P-M177-007
Isotopically labelledMoxonidine-d4Cat. No. P-M177-008CAS 1794811-52-1
NitrosamineN1,N2-DiNitroso MoxonidineCat. No. P-M177-009
NitrosamineN1-Nitroso MoxonidineCat. No. P-M177-010
NitrosamineN2-Nitroso MoxonidineCat. No. P-M177-011
Impurity4,6-Dichloro-2-methylpyrimidin-5-amineCat. No. P-M177-012CAS 39906-04-2
ImpurityMoxonidine Impurity 1Cat. No. P-M177-013CAS 100856-85-7
ImpurityDihydroxy MoxonidineCat. No. P-M177-014CAS 352457-32-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceMoxonidine CRSEDQM code Y0000226Family MoxonidineImpurityMoxonidine impurity A CRSEDQM code Y0000222Family MoxonidineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.